DENTSPLY SIRONA Inc.
XRAY
$16.26
$0.110.68%
| Weiss Ratings | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E+ | |||
| Rating Factors | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.24 | |||
| Price History | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.60% | |||
| 30-Day Total Return | -16.01% | |||
| 60-Day Total Return | -15.08% | |||
| 90-Day Total Return | -31.70% | |||
| Year to Date Total Return | -13.28% | |||
| 1-Year Total Return | -50.06% | |||
| 2-Year Total Return | -56.86% | |||
| 3-Year Total Return | -66.63% | |||
| 5-Year Total Return | -60.94% | |||
| 52-Week High % Change | -52.89% | |||
| 52-Week Low % Change | 4.43% | |||
| Price | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $34.28 | |||
| 52-Week Low Price | $15.47 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.21B | |||
| Enterprise Value | 5.21B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.56 | |||
| Earnings Per Share Growth | 626.78% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.85 | |||
| Price/Book (Q) | 1.65 | |||
| Enterprise Value/Revenue (TTM) | 1.37 | |||
| Price | $16.26 | |||
| Enterprise Value/EBITDA (TTM) | 9.11 | |||
| Enterprise Value/EBIT | 23.37 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 198.80M | |||
| Dividend Yield | 3.96% | |||
| Div. Per Share (Most Recent) | $0.16 | |||
| Dividend Per Share (TTM) | $0.64 | |||
| Payout Ratio (TTM) | -13.85% | |||
| Dividend Per Share (Most Recent) | $0.16 | |||
| Company Info | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 848 0137 | |||
| Address | 13320-B Ballantyne Corporate Place Charlotte, NC 28277-3607 | |||
| Website | www.dentsplysirona.com | |||
| Country | United States | |||
| Year Founded | 1877 | |||
| Profitability | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.87% | |||
| Profit Margin | -23.99% | |||
| Management Effectiveness | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.12% | |||
| Return on Equity | -- | |||
| Income Statement | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.79B | |||
| Total Revenue (TTM) | 3.79B | |||
| Revenue Per Share | $19.08 | |||
| Gross Profit (TTM) | 1.97B | |||
| EBITDA (TTM) | 572.00M | |||
| EBIT (TTM) | 223.00M | |||
| Net Income (TTM) | -910.00M | |||
| Net Income Avl. to Common (TTM) | -910.00M | |||
| Total Revenue Growth (Q YOY) | -10.57% | |||
| Earnings Growth (Q YOY) | -694.44% | |||
| EPS Diluted (TTM) | -4.56 | |||
| EPS Diluted Growth (Q YOY) | -778.06% | |||
| Balance Sheet | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 302.00M | |||
| Cash Per Share (Q) | $1.52 | |||
| Total Current Assets (Q) | 1.75B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.94B | |||
| Current Ratio (Q) | 1.099 | |||
| Book Value Per Share (Q) | $9.77 | |||
| Total Assets (Q) | 5.75B | |||
| Total Current Liabilities (Q) | 1.59B | |||
| Total Debt (Q) | 2.30B | |||
| Total Liabilities (Q) | 3.81B | |||
| Total Common Equity (Q) | 1.94B | |||
| Cash Flow | XRAY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -197.00M | |||
| Cash from Financing (TTM) | -302.00M | |||
| Net Change in Cash (TTM) | -62.00M | |||
| Levered Free Cash Flow (TTM) | 400.75M | |||
| Cash from Operations (TTM) | 461.00M | |||
